AwardedFinlandGoods
Tisagenlekleuseelivalmiste (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikuispotilaille
- Published
- Published 8 December 2025
Overview
Tisagenlekleuseelivalmiste (Kymriah 1.2x10e6-6x10e8 solua infuusioneste) Terveydenhuollon palveluvalikoimaneuvoston (Palko) suosituksen (13.3.2019) mukaiseen käyttöön lapsipotilaiden ja korkeintaan 25 vuoden ikäisten nuorten aikuispotilaiden B-solulinjan akuutin lymfoblastisen leukemian (ALL) hoidossa, kun sairaus ei ole reagoinut aiempaan hoitoon (hoitoresistentti), kun se on uusiutunut kaksi kertaa tai useammin tai kun se on uusiutunut kantasolusiirron jälkeen.
Key details
- Country
- Finland
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 8 December 2025
Pharmaceutical products
Award outcome
- Awarded value
- €2,000,000
- Award date
- 28 December 2025
- Contract period
- 1 January 2026 → 31 December 2027
- Novartis Finland Oy
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
28 January 2026
Contract Notice
8 December 2025
Contracting authority
HUS Group, the joint authority for Helsinki and Uusimaa
Procuring entityHelsinki, Finland
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.